Skip to main content
. 2021 Mar 11;11(3):498. doi: 10.3390/diagnostics11030498

Table 3.

Patients characteristics with mapping pattern B.

Characteristics PDAC Non-PDAC p-Value
Number 11 13
Age (year) 66.3 ± 12.8 65 ± 10.4 p = 0.5236
(44–87) (48–84)
BMI (kg/m2) 22.7 ± 3.29 23.1 ± 4.14 p = 0.8696
(17.0–27.8) (18.9–31.2)
Diabetes mellitus, n (%) 2 (18.2) 5 (38.5) p = 0.6576
Smoking, n (%) 4 (36.4) 4 (30.8) p = 0.8190
Alcohol, n (%) 1 (9.1) 3 (23.1) p = 0.5207
Lesion
SWE value (kPa) 34.7 26.2 p = 0.0987
IQR (23.1–69.1) (12.8–44.6)
SD (kPa) 25.6 17.0 p = 0.2466
IQR (12.2–29.9) (6.93–25.3)
kPa/SD 1.58 1.28 p = 0.7721
IQR (1.17–1.97) (1.12–2.28)
Parenchyma
SWE value (kPa) 10.2 9.86 p = 0.6021
IQR (9.8–12.9) (9.22–15.1)
SD (kPa) 3.38 5.83 p = 0.1320
IQR (2.49–5.48) (4.10–6.90)
kPa/SD 3.57 1.80 p = 0.2024
IQR (1.82–5.86) (1.12–2.28)
SWE tumor/non-tumor ratio
SWE value (kPa) 3.89 1.53 p = 0.0045
IQR (2.37–5.17) (1.12–1.78)

PDAC, pancreatic ductal adenocarcinoma; BMI, body mass index.